期刊
FRONTIERS IN IMMUNOLOGY
卷 12, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2021.663203
关键词
idiopathic pulmonary fibrosis; mesenchymal stem; stromal cells; regulatory T cells; regulatory B cells; macrophages; myeloid-derived suppressor cells; pharmacotherapy; transplantation
类别
资金
- University of Tubingen [2461-0-0, 2458-0-0, 2606-0-0]
The immune system plays a crucial role in interstitial lung diseases, especially in the development and treatment response of pulmonary fibrosis. Understanding immune regulation is essential for the development of new therapeutic approaches for idiopathic pulmonary fibrosis.
The immune system is receiving increasing attention for interstitial lung diseases, as knowledge on its role in fibrosis development and response to therapies is expanding. Uncontrolled immune responses and unbalanced injury-inflammation-repair processes drive the initiation and progression of idiopathic pulmonary fibrosis. The regulatory immune system plays important roles in controlling pathogenic immune responses, regulating inflammation and modulating the transition of inflammation to fibrosis. This review aims to summarize and critically discuss the current knowledge on the potential role of regulatory immune cells, including mesenchymal stromal/stem cells, regulatory T cells, regulatory B cells, macrophages, dendritic cells and myeloid-derived suppressor cells in idiopathic pulmonary fibrosis. Furthermore, we review the emerging role of regulatory immune cells in anti-fibrotic therapy and lung transplantation. A comprehensive understanding of immune regulation could pave the way towards new therapeutic or preventive approaches in idiopathic pulmonary fibrosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据